CD79a
Price range: $295.00 through $1,360.00
Description
Product Description
CD79a antibody is an intracellular component of the signal transduction pathway of the B-cell Receptor, appearing at pre-B-cell stage and persisting until the plasma cell stage. Studies have shown that CD79a is found in a majority of acute leukemia of precursor-B-cell-type as well as B-cell neoplasms, B-cell lymphomas and some myelomas. It is not present in myeloid or T-cell lines. This antibody labels precursor B-cell acute lymphoblastic leukemia, and has been suggested as the most reliable B-cell marker for this disorder. CD79a is conserved across species, which may make it useful in the identification of B-cell lymphomas in species other than human.
Specifications
Specifications
| Weight | N/A |
|---|---|
| Dimensions | N/A |
| Intended Use | |
| Species Reactivity | |
| Source | |
| Clone | |
| Isotype | |
| Antigen | |
| Localization | |
| Positive Control |
Datasheets & SDS
| Download CE Marked IVD Datasheet |
| Download IVD Datasheet Without CE Mark |
| Download RUO Data Sheet for International |
| Download SDS Sheet |
Browse more documents for this product (IFUs, datasheets, translations, SDS, and more).
References
1. Milner RJ, et al. Onderstepoort J Vet Res. 1996 Dec; 63(4):309-313.
2. Astsaturov IA, et al. Leukemia. 1996 May; 10(5):769-73.
3. Chetty R, et al. J Clin Pathol. 1995 Nov; 48(11):1035-8.
4. Hemsley SW, et al. Immunol Cell Biol. 1995 Aug; 73(4):321-5.
5. Mason DY, et al. Blood. 1995 Aug; 86(4):1453-9.
![(L) Anaplastic large cell lymphoma and (R) Lung adenocarcinoma stained with ALK antibody [5A4]](https://biocare.net/wp-content/uploads/3041-247x296.jpg)
